Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease
Phase 2
Terminated
- Conditions
- Coronary Heart DiseaseChlamydophila Pneumoniae Infections
- Interventions
- Drug: Placebo oral capsuleDrug: Placebo Oral Tablet
- First Posted Date
- 2018-08-07
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Cadrock Pty. Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT03618108
- Locations
- 🇦🇺
Liverpool hospital, Liverpool, New South Wales, Australia
© Copyright 2025. All Rights Reserved by MedPath